Intravascular Ultrasound Findings Associated With Hydrodynamic Contrast Recanalization (HDR) of Coronary Chronic Total Occlusions
HDR is a novel CTO PCI technique that appears to facilitate intraplaque wire crossing without causing significant vessel injury. The presence of speckled plaque by IVUS is a unique feature of HDR that may suggest a mechanism underlying this technique. Additional studies are needed to confirm these findings.
Authors
- Emmanouil S. Brilakis (ORCID: https://orcid.org/0000-0001-9416-9701)
- Jonathan Hudson (ORCID: https://orcid.org/0000-0002-5128-8388)
- Salman Arain (ORCID: https://orcid.org/0000-0002-5810-4991)
- Akshitha Yarrabothula
- Antonio Colombo (ORCID: https://orcid.org/0000-0002-2940-2455)
- Angelo Nascimbene (ORCID: https://orcid.org/0000-0003-2876-1189)
- Lorenzo Azzalini (ORCID: https://orcid.org/0000-0001-9758-0360)
- Yutaka Tadano (ORCID: https://orcid.org/0000-0003-0566-4298)
- Tsutomu Fujita (ORCID: https://orcid.org/0000-0002-3651-6231)
- Mauro Carlino (ORCID: https://orcid.org/0000-0003-2326-4749)
- Bernardo Cortese (ORCID: https://orcid.org/0000-0002-5808-7810)
- M. Bilal Iqbal (ORCID: https://orcid.org/0000-0002-7864-7782)
- Biswajit Kar (ORCID: https://orcid.org/0000-0002-4777-5466)
Institutions
- Vita-Salute San Raffaele University (IT)
- University of Washington (US)
- Boston Scientific (United States) (US)
- Victoria Heart Institute Foundation (CA)
- Sapporo Science Center (JP)
- University Hospitals Cleveland Medical Center (US)
- Minneapolis Heart Institute Foundation (US)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Houston (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1002/ccd.70094
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association
- AstraZeneca
- Boston Scientific Corporation
- Abiomed
- Abbott Vascular